A recent study in Clinical Epidemiology and Global Health determined the importance of personalized treatment strategies in improving weight outcomes and glycemic control for managing type 2 diabetes mellitus (T2DM).
The study aimed to investigate the impact of various antihyperglycemic medications on weight fluctuations in patients with T2DM.
A total of 410 participants were included in the study. A prospective cohort study was done in patients with T2DM. Based on the study criteria, 392 were included, and 18 members were excluded from the study.
A significant association has been found between Metformin 500 mg and Voglibose 0.2 mg, as well as with GRBS Levels, while Metformin 500 mg was also found to be associated with weight loss. In the case of Glimepiride 1mg & Glimepiride 2 mg, a slight increase in weight was observed. The study reported a sligh weight loss with sitagliptin 100 mg, voglibose 0.2 mg, teneligliptin 20 mg, and vildagliptin 50 mg.
Featured
Off
Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Key highlights
- Individualized medication plans that address both blood sugar control and weight management are effective in managing type 2 diabetes.
- Optimizing both glycemic control and weight outcomes should be a core focus in type 2 diabetes treatment strategies.
- Further studies to improve treatment guidelines and overall clinical outcomes in patients with type 2 diabetes is needed.
Source
Prasad PJC, Lavanya Y, Reddy PN, Banu DS, Rajavardhana T. Investigating the connection between diabetes drugs and weight loss in patients with type II diabetes mellitus: a prospective cohort study. Clin Epidemiol Glob Health. 2025;20:102135. doi:10.1016/j.cegh.2025.102135
Thumbnail
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
The research determined the importance of personalized treatment strategies in improving weight outcomes and glycemic control for managing type 2 diabetes mellitus.
User Segments
Release Date
Featured Order
0
Is Paid
0